Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.
Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.
Curr Drug Deliv. 2024;21(7):978-992. doi: 10.2174/1567201820666230621124953.
Until the drugs enter humans life, they may face problems in transportation, drug delivery, and metabolism. These problems can cause reducing drug's therapeutic effect and even increase its side effects. Together, these cases can reduce the patient's compliance with the treatment and complicate the treatment process. Much work has been done to solve or at least reduce these problems. For example, using different forms of a single drug molecule (like Citalopram and Escitalopram); slight changes in the drug's molecule like Meperidine and α-Prodine, and using carriers (like Tigerase®). PEGylation is a recently presented method that can use for many targets. Poly Ethylene Glycol or PEG is a polymer that can attach to drugs by using different methods and resulting sustained release, controlled metabolism, targeted delivery, and other cases. Although they will not necessarily lead to an increase in the effect of the drug, they will lead to the improvement of the treatment process in certain ways. In this article, the team of authors has tried to collect and carefully review the best cases based on the PEGylation of drugs that can help the readers of this article.
在药物进入人体之前,它们可能会在运输、药物传递和代谢方面遇到问题。这些问题可能会降低药物的治疗效果,甚至增加其副作用。所有这些情况都会降低患者对治疗的依从性,并使治疗过程复杂化。为了解决或至少减少这些问题,已经做了很多工作。例如,使用单一药物分子的不同形式(如西酞普兰和艾司西酞普兰);药物分子的微小变化,如哌替啶和α-丙啶,并使用载体(如 Tigerase®)。聚乙二醇化是一种最近提出的方法,可以用于许多目标。聚乙二醇或 PEG 是一种聚合物,可以通过不同的方法与药物结合,从而实现持续释放、控制代谢、靶向递送等效果。尽管它们不一定会提高药物的疗效,但会在某些方面改善治疗过程。在本文中,作者团队试图收集和仔细审查基于药物聚乙二醇化的最佳案例,以帮助本文的读者。